Journals / Türk Osteoporoz Dergisi / 2014 / Cilt: 20 - Sayı: 2

Pandemic Era: Vitamin D Deficiency and Insufficiency

Çağın Pandemisi: D Vitamini Eksikliği ve Yetersizliği

Pages
71–74
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we aimed to define Vitamin D deficiency and insufficiency which is currently widespread in adults, and to provide a current approach to the treatment methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin D is not only a fat-soluble vitamin, but also a group of hormone and hormone precursor sterols that can be synthesized endogenously in appropriate biological conditions.
📊
Key Findings & Data:Vitamin D deficiency is now recognized as a global epidemic. 25(OH) Vitamin D levels under 20 ng/mL is accepted as Vitamin D deficiency, levels between 21-29 ng/mL as insufficiency, over 30 ng/mL as sufficient levels (preferred range is between 40-60 ng/mL), and over 150 ng/mL as Vitamin D intoxication.
💡
Conclusion & Impact:In this review, we aimed to define Vitamin D deficiency and insufficiency which is currently widespread in adults, and to provide a current approach to the treatment methods.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vitamin D is not only a fat-soluble vitamin, but also a group of hormone and hormone precursor sterols that can be synthesized endogenously in appropriate biological conditions. Its most profound effect is on calcium and phosphorus metabolism, and on bone mineralization. In recent years, it was reported that Vitamin D deficiency and insufficiency are related with many chronic diseases such as widespread cancers, cardiovascular diseases, metabolic syndromes, infectious diseases and autoimmune diseases. Vitamin D deficiency is also a defined risk factor for osteoporosis, falls and fractures. Vitamin D deficiency is now recognized as a global epidemic. 25(OH) Vitamin D levels under 20 ng/mL is accepted as Vitamin D deficiency, levels between 21-29 ng/mL as insufficiency, over 30 ng/mL as sufficient levels (preferred range is between 40-60 ng/mL), and over 150 ng/mL as Vitamin D intoxication. Vitamin D deficiency leads to ricketts clinics in children and osteomalacia clinics in adults. In this review, we aimed to define Vitamin D deficiency and insufficiency which is currently widespread in adults, and to provide a current approach to the treatment methods.

Özet

D vitamini; yağda eriyen vitaminler arasında yer almakta olup aynı zamanda endojen olarak uygun biyolojik ortamda sentezlenebildikleri için hormon ve hormon öncüleri olan bir grup steroldür. En önemli etkisi kalsiyum, fosfor metabolizması ve kemik mineralizasyonu üzerinedir. Son yıllarda, D vitamini eksikliği ve yetersizliğinin, yaygın kanserler, kardiyovasküler hastalıklar, metabolik sendrom, enfeksiyöz ve otoimmun hastalıkların dahil olduğu bir çok kronik hastalıklarla ilişki içinde olduğu bulunmuştur. Aynı zamanda D vitamini eksikliği osteoporoz, düşme ve kırıklar için tanımlanmış bir risk faktörüdür. D vitamini eksikliği artık küresel bir salgın olarak kabul edilmektedir. 25(OH)D düzeyi 20 ng/mL'den düşük ise D vitamini eksikliği, 21 ile 29 ng/mL arasında ise D vitamini yetersizliği, 30 ng/mL'den yüksek ise yeterli düzey (tercih edilen aralık 40-60 ng/mL) ve 150 ng/mL'den yüksek ise D vitamini intoksikasyonu olarak kabul edilmektedir. D vitamini eksikliği çocuklarda rikets, erişkinlerde ise osteomalazi klinik tablosuna neden olmaktadır. Bu derlemede; günümüzde çok yaygın olan yetişkinlerdeki D vitamini yetersizliği ve eksikliğinin tanımlanması ve tedavi yönetimine güncel bir yaklaşım sunmayı amaçladık.

🔖

Cite This Article

TOSUN, A., ALKAN, B. M., FİDAN, F. (2022). Pandemic Era: Vitamin D Deficiency and Insufficiency. Türk Osteoporoz Dergisi, Cilt: 20 - Sayı: 2, 71–74. https://ajindex.com/articles/639839

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Champe PC, Harvey RA, Ferrier DR. Biyokimya. Çeviri Editörü: Ulukaya E. Lippincott's Illustrated Reviews Serisinden. 3. Baskı. Nobel Tıp Kitapevleri
  2. Bringhurst FR, Demay MB, Krane SM, Kronenberg HM. Bone and Mineral Metabolism in Health and Disease. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. 16th edition. New York:MCGraw-Hill Companies
  3. p. 2238-86. 3. Holick MF. Vitamin D: a D-lightful health perspective. Nutr Rev 2008
  4. Hyppönen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrom at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008
  5. Pearce SHS, Cheetham TD. Diagnosis and management of vitamin D deficiency. BMJ 2010
  6. b5664. 6. Wacker M, Holick MF. Vitamin D-Effects on Skeletal and Extraskeletal Health and the Need for Supplementation. Nutrients 2013
  7. Uçar F, Taşlıpınar MY, Soydaş AÖ, Özcan N. Ankara Etlik İhtisas Eğitim Araştırma Hastanesi'ne Başvuran Hastalarda 25-OH Vitamin D Düzeyleri. Eur J Basic Med Sci 2012
  8. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality- a review of recent evidence. Autoimmun Rev 2013
  9. Öngen B, Kabaroğlu C, Parıldar Z. D Vitamini'nin Biyokimyasal ve Laboratuvar Değerlendirmesi. Türk Klinik Biyokimya Dergisi 2008
  10. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon MC, Hanley DA, Heaney RP et al. Evaluation,Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011
  11. Uğurlu H. Osteomalazi, Paget Hastalığı. In: Beyazova M, GökçeKutsal Y, editörler. Fiziksel Tıp ve Rehabilitasyon, Güneş Kitabevi Ankara
  12. p.1894-902. 12. Lane NE. Metabolic Bone Disease. In: Firestein GS, Budd RC, Harris ED, Mclnnes IB, Ruddy S, Sergent JS, editors. Textbook of Rheumatoogy Kelley's, Saunders Elsevier
  13. p.1579-99. 13. Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007
  14. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005
  15. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A poo